Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
21 – 65
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Other
Participants needed
60 (estimated)
Sponsor
Deepak C. D'Souza · Other
Who this trial is looking for
This trial is looking for adults aged 21 to 65 who have depression or are healthy. Participants will take DMT and help researchers understand its effects on mood and brain activity.
Are You a Good Fit for This Trial?
You may be able to join if
I am between 21 and 65 years old.
I have a body mass index (BMI) between 18-35.
I am willing to avoid medications not approved by the study doctor.
I do not use street drugs or alcohol.
I have a major depressive disorder and did not respond well to antidepressants.
I am receiving treatment for depression and will continue during the study.
I agree to allow the research team to communicate with my mental health provider.
I will use effective birth control if I am sexually active and able to get pregnant.
You may not be able to join if
I have significant problems with blood pressure.
I am currently pregnant or breastfeeding.
I have a history of substance use disorder.
I have a current psychiatric disorder other than major depression.
I have had significant cardiovascular disease.
I have cognitive dysfunction that affects my ability to participate.
I have any unstable medical conditions.
I have a history of serotonin syndrome.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
The goal of this phase 1 study is to investigate the safety and efficacy of dimethyltryptamine (DMT) in individuals with depression and healthy controls. We hypothesize that administration of DMT will result in decreases in depression, associated symptoms, and neuroplastic changes in depressed subjects. We expect that DMT will induce changes in neuroplasticity as indexed using electroencephalograp…
The goal of this phase 1 study is to investigate the safety and efficacy of dimethyltryptamine (DMT) in individuals with depression and healthy controls. We hypothesize that administration of DMT will result in decreases in depression, associated symptoms, and neuroplastic changes in depressed subjects. We expect that DMT will induce changes in neuroplasticity as indexed using electroencephalographic (EEG) measures and tasks in both depressed individuals and healthy volunteers, though to different degrees. These neuronal changes may in parallel cause changes in mood measured both in healthy and depressed subjects, which will be captured using appropriate psychometric measures of mood.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Some Common Inclusion Criteria:
1. Males and females
2. Age 21 to 65 years
3. Body mass index between 18-35 kg/m2
4. Willing to refrain from taking any medications not approved by the study physician
5. Willing to refrain from using street drugs and alcohol
6. Negative urine drug screen
7. Willing …
Some Common Inclusion Criteria:
1. Males and females
2. Age 21 to 65 years
3. Body mass index between 18-35 kg/m2
4. Willing to refrain from taking any medications not approved by the study physician
5. Willing to refrain from using street drugs and alcohol
6. Negative urine drug screen
7. Willing and able to abstain from smoking throughout each test session
8. Women who are of child-bearing potential (WOCBP) and sexually active must be willing to practice an effective means of birth control
9. Willing not to drive to and from the testing session
Some Inclusion Criteria for Subjects with MDD:
1. Diagnosed with Major Depressive Disorder (MDD)
2. Unsatisfactory response to antidepressants
3. Engaged in treatment for depression with a clinician and willing to continue treatment for the duration of the study
4. Not engaged in treatment
5. Consent to allow the research team to communicate with mental health provider.
6. Only subjects who get support for participation in the trial from their mental health clinician will be eligible to be enrolled in the study
Some Common Exclusion Criteria:
1. Medications that might significantly interfere with the effects of the study medications
2. Cognitive dysfunction that could interfere with study participation
3. Alcohol or substance use disorder
4. Any lifetime history of hallucinogen use disorder
5. Regular use or misuse of hallucinogens
6. History of intolerance to perceptual altering drugs
7. Significant blood pressure problems
8. Pregnancy or currently breast feeding (lactation)
9. Any unstable medical conditions
10. Significant cardiovascular disease
11. Significantly abnormal laboratory test results
12. History of serotonin syndrome
Some Exclusion criteria for MDD subjects:
1. Current primary psychiatric disorder other than MDD
2. Medically significant condition rendering unsuitability for the study
Some Exclusion criteria for healthy controls:
1. No current DSM-V psychiatric disorder, excluding nicotine and caffeine use disorder
2. No family history of serious mental illness (e.g., schizophrenia, bipolar disorder)
Some Inclusion criteria for healthy controls:
1. No current DSM-5 psychiatric disorder, excluding nicotine and caffeine use disorder
2. No lifetime use of psychiatric medication \>3 months (proxy for psychiatric disorders)
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.